Bionano Genomics (BNGO) on Thursday disclosed a combined public offering of shares and accompanying warrants to raise an expected $9 million in proceeds.

The company will issue up to 2 million shares of common stock, together with Series E and Series F warrants, at an assumed combined price of $4.92 per share and accompanying warrants, according to a regulatory filing.

The company said it intends to use net proceeds from the offering for working capital and general corporate purposes.

Bionano said that the offering will terminate on Oct. 11.

Price: 4.88, Change: -0.04, Percent Change: -0.73